125 related articles for article (PubMed ID: 19087624)
21. Expression of p27 and apoptosis in oral leukoplakia.
Tsuzuki H; Fujieda S; Sunaga H; Narita N; Tokuriki M; Saito H
Anticancer Res; 2003; 23(2B):1265-70. PubMed ID: 12820381
[TBL] [Abstract][Full Text] [Related]
22. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias.
Chen YK; Huang AH; Cheng PH; Yang SH; Lin LM
Clin Oral Investig; 2013 Apr; 17(3):921-32. PubMed ID: 22669485
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
25. [Immunohistochemical study of benign lymphoadenosis of oral mucosa].
Li SX; Yu SF; Sun KH
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):410-3. PubMed ID: 15498351
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.
Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235
[TBL] [Abstract][Full Text] [Related]
27. Integrin receptors and their relationship to cellular proliferation and differentiation of oral squamous cell carcinoma. A quantitative immunohistochemical study.
Kosmehl H; Berndt A; Katenkamp D; Hyckel P; Stiller KJ; Gabler U; Langbein L; Reh T
J Oral Pathol Med; 1995 Sep; 24(8):343-8. PubMed ID: 7500289
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy.
Shirasuna K; Hayashido Y; Sugiyama M; Yoshioka H; Matsuya T
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):349-53. PubMed ID: 2024456
[TBL] [Abstract][Full Text] [Related]
29. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
31. Midkine expression in oral squamous cell carcinoma and leukoplakia.
Jham BC; Costa NL; Silva JM; de Miranda AC; Oliveira JC; Silva TA; Batista AC
J Oral Pathol Med; 2012 Jan; 41(1):21-6. PubMed ID: 21595751
[TBL] [Abstract][Full Text] [Related]
32. Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions.
Sunaga H; Fujieda S; Tsuzuki H; Asamoto K; Fukuda M; Saito H
Anticancer Res; 2001; 21(4B):2901-6. PubMed ID: 11712784
[TBL] [Abstract][Full Text] [Related]
33. Cytomorphometric analysis of squames obtained from normal oral mucosa and lesions of oral leukoplakia and squamous cell carcinoma.
Ramaesh T; Mendis BR; Ratnatunga N; Thattil RO
J Oral Pathol Med; 1998 Feb; 27(2):83-6. PubMed ID: 9526735
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
[TBL] [Abstract][Full Text] [Related]
35. Analysis of basement membrane structure and inflammation during the development of esophageal squamous cell carcinoma in the Chinese Chaoshan high risk region.
Zhang GH; Su M; Tian DP; Huang HH; Wu XY; Zheng RM; Li QS
Cancer Invest; 2008; 26(3):296-305. PubMed ID: 18317971
[TBL] [Abstract][Full Text] [Related]
36. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
37. The association between epithelial proliferation and disease progression in the oral mucosa.
Macluskey M; Ogden GR; Green M; Chisholm DM; Schor SL; Schor AM
Oral Oncol; 1999 Jul; 35(4):409-14. PubMed ID: 10645407
[TBL] [Abstract][Full Text] [Related]
38. [The expression of urokinase-type plasminogen activator in oral squamous cell carcinoma].
Liang X; Mao Z; He Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):147-9. PubMed ID: 12838705
[TBL] [Abstract][Full Text] [Related]
39. Proliferation and invasion factors in HIV-associated dysplastic and nondysplastic oral warts and in oral squamous cell carcinoma: an immunohistochemical and RT-PCR evaluation.
Regezi JA; Dekker NP; Ramos DM; Li X; Macabeo-Ong M; Jordan RC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):724-31. PubMed ID: 12464898
[TBL] [Abstract][Full Text] [Related]
40. [Precancers of the oral mucosa: clinic, diagnostics].
Rabinovich OF; Rabinovich IM; Babichenko II; Umarova KV; Bekmurzova LF
Stomatologiia (Mosk); 2024; 103(2):5-11. PubMed ID: 38741528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
